176 related articles for article (PubMed ID: 31763563)
1. Imidazo[2,1-
Nagireddy PKR; Kommalapati VK; Siva Krishna V; Sriram D; Tangutur AD; Kantevari S
ACS Omega; 2019 Nov; 4(21):19382-19398. PubMed ID: 31763563
[TBL] [Abstract][Full Text] [Related]
2. Rational design of novel microtubule targeting anticancer drugs N-imidazopyridine noscapinoids: Chemical synthesis and experimental evaluation based on in vitro using breast cancer cells and in vivo using xenograft mice model.
Pragyandipta P; Pedapati RK; Reddy PK; Nayek A; Meher RK; Guru SK; Kantevari S; Naik PK
Chem Biol Interact; 2023 Sep; 382():110606. PubMed ID: 37330181
[TBL] [Abstract][Full Text] [Related]
3. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.
Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK
J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458
[TBL] [Abstract][Full Text] [Related]
4. Rational design, chemical synthesis and cellular evaluation of novel 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents.
Patel AK; Meher RK; Reddy PK; Pedapati RK; Pragyandipta P; Kantevari S; Naik MR; Naik PK
J Mol Graph Model; 2021 Jul; 106():107933. PubMed ID: 33991960
[TBL] [Abstract][Full Text] [Related]
5. 9-Ethynyl noscapine induces G2/M arrest and apoptosis by disrupting tubulin polymerization in cervical cancer.
Nagireddy PKR; Kumar D; Kommalapati VK; Pedapati RK; Kojja V; Tangutur AD; Kantevari S
Drug Dev Res; 2022 May; 83(3):605-614. PubMed ID: 34612529
[TBL] [Abstract][Full Text] [Related]
6. The synthesis and biological evaluation of multifunctionalised derivatives of noscapine as cytotoxic agents.
Debono AJ; Mistry SJ; Xie J; Muthiah D; Phillips J; Ventura S; Callaghan R; Pouton CW; Capuano B; Scammells PJ
ChemMedChem; 2014 Feb; 9(2):399-410. PubMed ID: 24339417
[TBL] [Abstract][Full Text] [Related]
7. Rational design of novel N-alkyl amine analogues of noscapine, their chemical synthesis and cellular activity as potent anticancer agents.
Meher RK; Pragyandipta P; Pedapati RK; Nagireddy PKR; Kantevari S; Nayek AK; Naik PK
Chem Biol Drug Des; 2021 Sep; 98(3):445-465. PubMed ID: 34051055
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of N-substituted noscapine analogues.
DeBono AJ; Xie JH; Ventura S; Pouton CW; Capuano B; Scammells PJ
ChemMedChem; 2012 Dec; 7(12):2122-33. PubMed ID: 23055449
[TBL] [Abstract][Full Text] [Related]
9. Rational design, synthesis, and biological evaluation of third generation α-noscapine analogues as potent tubulin binding anti-cancer agents.
Manchukonda NK; Naik PK; Santoshi S; Lopus M; Joseph S; Sridhar B; Kantevari S
PLoS One; 2013; 8(10):e77970. PubMed ID: 24205049
[TBL] [Abstract][Full Text] [Related]
10. Development of 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents for the management of breast cancer.
Meher RK; Pragyandipta P; Reddy PK; Pedaparti R; Kantevari S; Naik PK
J Biomol Struct Dyn; 2022; 40(23):13136-13153. PubMed ID: 34583618
[TBL] [Abstract][Full Text] [Related]
11.
Meher RK; Nagireddy PKR; Pragyandipta P; Kantevari S; Singh SK; Kumar V; Naik PK
J Biomol Struct Dyn; 2022 Sep; 40(15):6725-6736. PubMed ID: 33627059
[TBL] [Abstract][Full Text] [Related]
12. A Comprehension into Target Binding and Spatial Fingerprints of Noscapinoid Analogues as Inhibitors of Tubulin.
Mandavi S; Verma SK; Banjare L; Dubey A; Bhatt R; Thareja S; Jain AK
Med Chem; 2021; 17(6):611-622. PubMed ID: 31951171
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Functional Studies on Noscapine and Cotarnine Amino Acid Derivatives as Antitumor Agents.
Davarzani Z; Salehi P; Asghari SM; Bararjanian M; Hamrahi Mohsen A; Dehghan Harati H
ACS Omega; 2023 Dec; 8(48):45502-45509. PubMed ID: 38075843
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel anti-cancer agents by the synthesis and cellular screening of a noscapine-based library.
Nemati F; Bischoff-Kont I; Salehi P; Nejad-Ebrahimi S; Mohebbi M; Bararjanian M; Hadian N; Hassanpour Z; Jung Y; Schaerlaekens S; Lucena-Agell D; Oliva MA; Fürst R; Nasiri HR
Bioorg Chem; 2021 Oct; 115():105135. PubMed ID: 34303039
[TBL] [Abstract][Full Text] [Related]
15. 9-Arylimino noscapinoids as potent tubulin binding anticancer agent: chemical synthesis and cellular evaluation against breast tumour cells.
Patel AK; Meher RK; Nagireddy PK; Pragyandipta P; Pedapati RK; Kantevari S; Naik PK
SAR QSAR Environ Res; 2021 Apr; 32(4):269-291. PubMed ID: 33687299
[TBL] [Abstract][Full Text] [Related]
16. Insights into the structure and tubulin-targeted anticancer potential of N-(3-bromobenzyl) noscapine.
Cheriyamundath S; Mahaddalkar T; Reddy Nagireddy PK; Sridhar B; Kantevari S; Lopus M
Pharmacol Rep; 2019 Feb; 71(1):48-53. PubMed ID: 30465924
[TBL] [Abstract][Full Text] [Related]
17. Combined molecular dynamics and continuum solvent approaches (MM-PBSA/GBSA) to predict noscapinoid binding to γ-tubulin dimer.
Suri C; Naik PK
SAR QSAR Environ Res; 2015 Jun; 26(6):507-19. PubMed ID: 26274780
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative Noscapinoids Bearing an Amidothiadiazole Scaffold as Apoptosis Inducers: Design, Synthesis and Molecular Docking.
Kumar Pedapati R; Pragyandipta P; Pranathi Abburi N; Chirra N; Kantevari S; Naik PK
Chem Biodivers; 2023 Feb; 20(2):e202201089. PubMed ID: 36690497
[TBL] [Abstract][Full Text] [Related]
19. Development of 9-(
Pragyandipta P; Naik MR; Bastia B; Naik PK
3 Biotech; 2023 Feb; 13(2):38. PubMed ID: 36636578
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel biaryl type α-noscapine congeners.
Manchukonda NK; Naik PK; Sridhar B; Kantevari S
Bioorg Med Chem Lett; 2014 Dec; 24(24):5752-5757. PubMed ID: 25453814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
